Cargando…
MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma
Hypoxia is a common feature in solid tumours. In glioma, it is considered the major driving force for tumour angiogenesis and correlates with enhanced resistance to conventional therapies, increased invasiveness and a poor prognosis for patients. Here we describe, for the first time, that miR675-5p,...
Autores principales: | Lo Dico, Alessia, Costa, Viviana, Martelli, Cristina, Diceglie, Cecilia, Rajata, Francesca, Rizzo, Aroldo, Mancone, Carmine, Tripodi, Marco, Ottobrini, Luisa, Alessandro, Riccardo, Conigliaro, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893639/ https://www.ncbi.nlm.nih.gov/pubmed/27279905 http://dx.doi.org/10.7150/thno.14700 |
Ejemplares similares
-
MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells
por: Costa, Viviana, et al.
Publicado: (2017) -
The Multifaceted Role of CMA in Glioma: Enemy or Ally?
por: Lo Dico, Alessia, et al.
Publicado: (2021) -
Optical imaging probes in oncology
por: Martelli, Cristina, et al.
Publicado: (2016) -
Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide
por: Lo Dico, Alessia, et al.
Publicado: (2018) -
Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma
por: Lo Dico, Alessia, et al.
Publicado: (2019)